Iqvia Strengthens Global Position Ahead of Earnings Report

As the market anticipates its upcoming financial release, Iqvia has announced a significant expansion of its strategic footprint through a major new partnership. The data and research services provider is enhancing its technological capabilities while managing its balance sheet, setting the stage for its fourth-quarter and full-year 2025 results announcement this week.

A key development is a newly formed, long-term collaboration with the pharmaceutical company Boehringer Ingelheim, spanning 59 countries. The core of this partnership involves utilizing Iqvia’s DaaS+ technology platform to harmonize the pharma firm’s global market data. The initiative aims to streamline and improve the efficiency of new product launches across these international markets. This move highlights an industry-wide Read more...